The United States of America; as Represented by the Secretary; Department of Health and Human Servic
发明人:
Ian Antheni MYLES,Sandip K. DATTA
申请号：
US16848587
公开号：
US20200254029A1
申请日:
2020.04.14
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable Gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
